- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-SOX5
SOX5 Polyclonal Antibody for WB, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris et plus (1)
Applications
WB, IF, IHC, ELISA
Conjugaison
Non conjugué
N° de cat : 13216-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules A549, cellules MG U-87, cellules SH-SY5Y, tissu hépatique de souris |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:2000-1:10000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 3 publications below |
WB | See 7 publications below |
IHC | See 4 publications below |
IF | See 1 publications below |
Informations sur le produit
13216-1-AP cible SOX5 dans les applications de WB, IF, IHC, ELISA et montre une réactivité avec des échantillons Humain, souris
Réactivité | Humain, souris |
Réactivité citée | rat, Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | SOX5 Protéine recombinante Ag4092 |
Nom complet | SRY (sex determining region Y)-box 5 |
Masse moléculaire calculée | 763 aa, 84 kDa |
Poids moléculaire observé | 68-70 kDa |
Numéro d’acquisition GenBank | BC029220 |
Symbole du gène | SOX5 |
Identification du gène (NCBI) | 6660 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
Sex determining region Y-box protein 5 (SOX5) is a member of the SOX family, which was identified based on the conserved homology of the high-mobility group DNA-binding motif. It has been reported that SOX5 is involved in the regulation of embryonic development, and is associated with various cancer types, including prostate cancer, glioblastoma, hepatocellular carcinoma, osteosarcoma and nasopharyngeal carcinoma. SOX5 has 5 isoforms with the molecular mass of 42, 71 and 82-84 kDa. (PMID: 30854049)
Protocole
Product Specific Protocols | |
---|---|
WB protocol for SOX5 antibody 13216-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Nat Commun VCAM1 acts in parallel with CD69 and is required for the initiation of oligodendrocyte myelination. | ||
Pharmacol Res Cyclo-(Phe-Tyr) as a novel cyclic dipeptide compound alleviates ischemic/reperfusion brain injury via JUNB/JNK/NF-κB and SOX5/PI3K/AKT pathways. | ||
Cell Oncol (Dordr) Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells.
| ||
Phytomedicine Transcriptomics, molecular docking, and cross-resistance profiling of nobiletin in cancer cells and synergistic interaction with doxorubicin upon SOX5 transfection.
| ||
Lab Invest Sox13 promotes hepatocellular carcinoma metastasis by transcriptionally activating Twist1. | ||
Mol Cell Biochem Expression profiles of Sox transcription factors within the postnatal rodent testes. |